Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(50.0%)
Phase 1
2(50.0%)
4Total
N/A(2)
Phase 1(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07231224Not ApplicableCompleted

A Study of Myofunctional Therapy After Sleep Apnea Surgery

Role: collaborator

NCT01173172Phase 1Completed

Boron Neutron Capture Therapy (BNCT) for Locally Recurrent Head and Neck Cancer

Role: collaborator

NCT03941301Not ApplicableCompleted

Light Therapy on Major Depression Disorder

Role: collaborator

NCT02004795Phase 1Unknown

BNCT and IG-IMRT for Recurrent Head and Neck Cancer

Role: collaborator

All 4 trials loaded